But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...
Contract development and manufacturing organization (CDMO) Rentschler Biopharma has announced a partnership with ...
Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while ...
HCPs are unwanted impurities requiring removal during manufacturing, but new trehalose technology significantly reduces HCPs ...
Contract development and manufacturing organization (CDMO) Samsung Biologics made a splash at the end of 2025, acquiring ...
With the first half of this discussion in BPI’s October 2025 issue, I introduced the basics of phased stability testing, a fundamental component of ensuring biopharmaceutical quality, safety, and ...
With less than two weeks before we greet 2026, the biopharmaceutical industry is slowing down, gearing up for the next big wave of news and events to kick off January. But before we can enter the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback